A Study of Antigen Presenting Dysfunction of Dendritic Cell from Peripheral Blood in the Patients with Connective Tissue Diseases

结缔组织病患者外周血树突状细胞抗原呈递功能障碍的研究

基本信息

  • 批准号:
    60570299
  • 负责人:
  • 金额:
    $ 1.02万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1985
  • 资助国家:
    日本
  • 起止时间:
    1985 至 1986
  • 项目状态:
    已结题

项目摘要

We succeeded in preparation of dendritic cell(DC) from human peripheral blood. In brief, mononuclear cells were obtained by Ficoll-Hypaque gradients from 50ml heparinized peripheral blood, and then cultured in Petri dish. Non-adherent cells were removed and adherent cells were cultured overhight. The DC were detached from the dish. The DC fraction was cultured in anti-human IgG coated plastic dish for the purpose of excluding of macrophage and B cell. Monoclonal antibodies to 3C10, Leul and Leul4 plus complement were added for killing each contaminating cells if needed. DC possessed characteristic prosseses and on its surface HLA-DR and C3bireceptor were present, but Fc-receptor, surface Ig and OKT 3 antigen absent. Functional study proved that DC was "active stimulator" in mixed lymphocyte reaction (MLR). Reduced MLR was well documentated in the patients with systemic lupus erythematosus(SLE). We examined SLE-DC function using MLR assay. New findings were obtained that major cause of reduced MLR in the patients with SLE resulted in impaired function of SLE-DC and not in T cells as before reported by several authors. DC formed characteristic cell aggregates with autologous or allogneic T cells (cluster). T cells formed cluster were mainly OKT4 positive. Cultured cluster supernatant was proved to contain some factors to generate SAC-stimulated B cells into antibody secreting cells(BSF). Supernatant from cluster formed by SLE-DC showed very low grade BSF activities, indicating that SLE-DC had functional abnormalities.
我们成功地从人外周血中制备了树突状细胞(DC)。简而言之,通过Ficoll-Hypaque梯度从50ml肝素化的外周血中获得单核细胞,然后在培养皿中培养。去除非贴壁细胞并将贴壁细胞培养在过高的温度下。 DC 与盘分离。将DC级分培养在抗人IgG包被的塑料皿中,以排除巨噬细胞和B细胞。如果需要,添加针对 3C10、Leul 和 Leul4 加补体的单克隆抗体以杀死每种污染细胞。 DC具有特征性的结构,其表面存在HLA-DR和C3双受体,但不存在Fc受体、表面Ig和OKT 3抗原。功能研究证明DC是混合淋巴细胞反应(MLR)的“主动刺激剂”。系统性红斑狼疮 (SLE) 患者的 MLR 降低已得到充分证实。我们使用 MLR 测定检查了 SLE-DC 功能。新的发现表明,SLE 患者 MLR 降低的主要原因是 SLE-DC 功能受损,而不是像之前几位作者报道的那样导致 T 细胞功能受损。 DC与自体或异体T细胞形成特征性细胞聚集体(簇)。形成簇的T细胞主要为OKT4阳性。培养簇上清液被证明含有一些使SAC刺激的B细胞生成抗体分泌细胞(BSF)的因子。 SLE-DC形成的簇的上清液显示出非常低等级的BSF活性,表明SLE-DC具有功能异常。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Teruhiko SUZUKI: "The Role of Dendritic Cell from Human Peripheral Blood in Mixed Lymphocyte Reaction" Japanese Jounal of Clinical Immunology.
Teruhiko SUZUKI:“人外周血树突状细胞在混合淋巴细胞反应中的作用”日本临床免疫学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
鈴木輝彦: "厚生省特定疾患混合性結合組織病調査研究班 昭和61年度研究報告書 末梢血樹状細胞とMCTDのautologous mixed lymphocyte reaction(AMLR)の関連について"
铃木辉彦:《厚生省指定疾病混合结缔组织病调查研究小组1985年关于外周血树突状细胞与MCTD的自体混合淋巴细胞反应(AMLR)关系的研究报告》
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Fumihiko IMAI: "Dysfunction of Dendritic Cell from Peripheral Blood in the Patients with Systemic Lupus Erythematosus" Japanese Journal of Clinical Immunology.
Fumihiko IMAI:“系统性红斑狼疮患者外周血树突状细胞功能障碍”,日本临床免疫学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Teruhiko SUZUKI: "The Cause of Reduced Autologous Mixed Lymphocyte Reaction(MLR) in Systemic Lupus Erythematosus to be Peripheral Dendritic Cell Dysfunction"
Teruhiko SUZUKI:“系统性红斑狼疮中自体混合淋巴细胞反应 (MLR) 减少的原因是外周树突状细胞功能障碍”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SUZUKI Teruhiko其他文献

SUZUKI Teruhiko的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SUZUKI Teruhiko', 18)}}的其他基金

Establishment of MHC humanized mouse and its application for drug development
MHC人源化小鼠的建立及其在药物开发中的应用
  • 批准号:
    18K06047
  • 财政年份:
    2018
  • 资助金额:
    $ 1.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Humanization of the mouse MHC region by chromosome engineering technology
利用染色体工程技术对小鼠MHC区域进行人源化
  • 批准号:
    15K18392
  • 财政年份:
    2015
  • 资助金额:
    $ 1.02万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)

相似海外基金

CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 1.02万
  • 项目类别:
Role of thymidylate synthetase in B cells of systemic lupus erythematosus
胸苷酸合成酶在系统性红斑狼疮B细胞中的作用
  • 批准号:
    23K07893
  • 财政年份:
    2023
  • 资助金额:
    $ 1.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Physical Activity Behaviors and Readiness for a Digital Health Physical Activity Intervention inOlder Adults with Systemic Lupus Erythematosus
患有系统性红斑狼疮的老年人的身体活动行为和数字健康身体活动干预的准备
  • 批准号:
    10726230
  • 财政年份:
    2023
  • 资助金额:
    $ 1.02万
  • 项目类别:
Splenic Modulation of SHP-2 Activity as a Therapeutic Option for Systemic Lupus Erythematosus
脾脏调节 SHP-2 活性作为系统性红斑狼疮的治疗选择
  • 批准号:
    10668102
  • 财政年份:
    2023
  • 资助金额:
    $ 1.02万
  • 项目类别:
PREVENT-SLE: Towards PREdiction and preVENTion of Systemic Lupus Erythematosus
PREVENT-SLE:系统性红斑狼疮的预测和预防
  • 批准号:
    EP/Y023560/1
  • 财政年份:
    2023
  • 资助金额:
    $ 1.02万
  • 项目类别:
    Research Grant
Interaction between chronic inflammation, pain, and brain function in systemic lupus erythematosus
系统性红斑狼疮慢性炎症、疼痛和脑功能之间的相互作用
  • 批准号:
    23K07903
  • 财政年份:
    2023
  • 资助金额:
    $ 1.02万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Engineered DNA-particles to model immune events in systemic lupus erythematosus
工程 DNA 颗粒模拟系统性红斑狼疮的免疫事件
  • 批准号:
    10644574
  • 财政年份:
    2023
  • 资助金额:
    $ 1.02万
  • 项目类别:
Development of a Novel, Targeted Small Molecule Inhibitor of the Nucleoside Salvage Pathway to Treat Systemic Lupus Erythematosus
开发一种新型核苷挽救途径靶向小分子抑制剂来治疗系统性红斑狼疮
  • 批准号:
    10755905
  • 财政年份:
    2023
  • 资助金额:
    $ 1.02万
  • 项目类别:
Defining the Role of Dynamic X Chromosome Inactivation in Age-Associated B Cells for Female-Biased Systemic Lupus Erythematosus
定义动态 X 染色体失活在年龄相关 B 细胞中对女性系统性红斑狼疮的作用
  • 批准号:
    10749337
  • 财政年份:
    2023
  • 资助金额:
    $ 1.02万
  • 项目类别:
The Exposome in Rheumatoid Arthritis and Systemic Lupus Erythematosus: EXACT Network Planning
类风湿关节炎和系统性红斑狼疮的暴露组:精确的网络规划
  • 批准号:
    10869439
  • 财政年份:
    2023
  • 资助金额:
    $ 1.02万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了